Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study

ConclusionsOur prospective trial involving 9 mCRPC patients initiating ARSi did not show significant modulation of PSMA expression measured on WB-PSMA PET at 1-week. This study was registered on clinicaltrials.gov (NCT04279561).

http://link.springer.com/10.1186/s13550-023-01048-4

Source: EJNMMI Research - October 30, 2023 Category: Radiology Source Type: research